Effects of histamine on immunophenotype and notch signaling in human HL-60 leukemia cells

Li Mei Yu1, Dai Xiong Chen, Qi Xin Zhou

  • 1The Key Laboratory of Cell Engineering in Guizhou Province, Affiliated Hospital of Zunyi Medical College, Zunyi Medical College, Zunyi, Guizhou Province, China. ylm6567@yahoo.com.cn

Insights

Histamine inhibits human leukemia cell growth and alters surface markers CD49d and CD31. These changes in immunophenotype occur independently of Notch signaling pathways.

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Surface molecules are key biomarkers for cell proliferation, differentiation, and interaction.
  • Notch signaling is crucial for developmental processes and cell-fate decisions.
  • Histamine influences hematopoietic cell development and is used in leukemia immunotherapy.

Purpose of the Study:

  • To investigate the effects of histamine on the immunophenotype and Notch signaling in human HL-60 leukemia cells.
  • To determine if histamine's effects on leukemia cell growth and surface marker expression involve Notch signaling.

Main Methods:

  • HL-60 leukemia cells were treated with varying concentrations of histamine.
  • Cell proliferation was assessed using growth curves and colony-forming efficiency assays.
  • Immunophenotypic changes were analyzed via flow cytometry, focusing on surface molecules like CD49d and CD31.
  • Notch signaling pathway components (Notch1, Notch4, Jagged1, Delta4, HES1) were quantified using real-time RT-PCR.

Main Results:

  • Histamine inhibited HL-60 cell growth in a dose-dependent manner.
  • Histamine treatment significantly decreased CD49d expression by 74% and increased CD31 expression by 53%.
  • Histamine did not significantly alter the expression of other tested surface molecules or key components of the Notch signaling pathway.

Conclusions:

  • Histamine effectively inhibits HL-60 leukemia cell proliferation.
  • Histamine modulates specific cell surface markers (CD49d and CD31), altering the immunophenotype.
  • The observed immunophenotypic alterations induced by histamine in HL-60 cells are not mediated by the Notch signaling pathway.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...